Plus more pharma news from the Pharmalittle newsletter.

Second-quarter sales of the blockbuster drug soared 67% on year, despite millions of U.S. patients using generic unbranded versions of the drug.

A new study in mice has found that muscle loss associated with weight loss from GLP-1 medications like Ozempic may not be as high as recently thought.

In an ongoing preclinical study, substantial progress in the development of a miniature, ultra long-acting, semaglutide implant, NPM-139 has been established by showing weight loss from a single ...

Weight loss medications such as Wegovy and Zepbound have garnered an enormous amount of attention recently for their ability to help some users lose significant amounts of weight relatively easily.

Three new studies suggest that Ozempic and related diabetes and weight loss drugs may help protect the brain from strokes.

Could popular diabetes and weight loss drugs like Ozempic actually protect your brain from stroke damage, or prevent strokes altogether? Three new studies presented at a major neurosurgery ...

A new study is leading to concerns about the long-term effects of weight loss drugs like Ozempic or Wegovy.

Novo Nordisk slashed its profit forecast owing to slower sales growth for its Ozempic diabetes and Wegovy weight-loss treatments in the U.S. Its blockbuster GLP-1 drugs have been losing market ...

Though GLP-1 drugs drive major weight loss, researchers warn they may fall short in improving heart and lung fitness. Protecting muscle mass may be key to unlocking their full health potential. Widely ...